Grifols S.A.

E:GRF 
(MADRID) 
 
28.94
Updated 18/08/2019
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 448,936
High 29.05
Low 28.75
Open 28.89
ISIN ES0171996087
Prev close 28.94
# of shares -
Market cap -
Intraday

Market closed
Grifols S.A.
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  28.94 1.3% Stock price increasing 1.3% Stock price increasing 22.3% Stock price increasing 23.0% Stock price increasing 17.0% Stock price increasing
Powered by TradingView

Company profile

Grifols SA is a Spain-based vertically integrated plasma derivative producer. Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 79% of sales in 2017. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics grew to almost 20% of revenue in 2014 with the acquisition of Novartis' diagnostics unit.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 August 2019 02:37:26
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB1 - 2019-08-21 03:37:26 - 2019-08-21 02:37:26 - 1000 - Website: OKAY